Results 341 to 350 of about 3,290,822 (384)
Human Papillomavirus and the Gardasil Vaccine: Medicalization and the Gendering of Bodies and Bodily Risk [PDF]
Camara, Lauren
core +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Latent papillomavirus infections and their regulation.
Current Opinion in Virology, 2013Model systems show that papillomavirus DNA can persist after lesion-regression, and be maintained in a subset of epithelial basal cells. These are very likely long-lived 'stem-cells' or 'stem-like cells', with latency arising via at least two distinct mechanisms. The first involves low-titre virus infection and the retention of viral DNA at levels that
J. Doorbar
semanticscholar +3 more sources
Human papillomavirus infections in children.
Pediatric Annals, 1994Human papillomavirus infections in children, particularly when occurring as condylomata acuminata, present a difficult and often puzzling problem. The possibility that the lesions were acquired through sexual contact mandates a careful and thorough ...
Lori D Frasier
semanticscholar +4 more sources
Human papillomavirus infection
Journal of the American Academy of Dermatology, 1989Of porri, verucae, and eondylomata of the pudenda. There remains a fourth species of venereal disease to be added to those which we have already described, viz, warty excrescences of the genitals, which sometimes succeed impure coition, but for the most part follow other porky disorders that have been iU managed. Sometimes they wither of themselves and
openaire +4 more sources
Human papillomavirus infection
Disease-a-Month, 2016Human papillomavirus (HPV) is a DNA virus that causes a variety of conditions including common warts, condyloma acuminata (anogenital warts), and multiple malignancies involving the squamous epithelium. HPV is a unique oncogenic infectious agent that causes cervical cancer, the second most common cancer in women worldwide.
Jack N. Hutter, Catherine F. Decker
openaire +3 more sources
EMC - Maladies Infectieuses, 2004
Resume Les papillomavirus (HPV) sont responsables d'affections cutaneomuqueuses benignes frequentes. Les lesions les plus connues sont les verrues et les condylomes. Au niveau anogenital, ils representent une authentique maladie sexuellement transmissible (MST).
S. Dalac, S. Douvier
openaire +2 more sources
Resume Les papillomavirus (HPV) sont responsables d'affections cutaneomuqueuses benignes frequentes. Les lesions les plus connues sont les verrues et les condylomes. Au niveau anogenital, ils representent une authentique maladie sexuellement transmissible (MST).
S. Dalac, S. Douvier
openaire +2 more sources
Papillomavirus infections--a major cause of human cancers.
Biochimica et Biophysica Acta, 1996The papillomavirus family represents a remarkably heterogeneous group of viruses. At present, 77 distinct genotypes have been identified in humans and partial sequences have been obtained from more than 30 putative novel genotypes. Geographic differences
H. zur Hausen
semanticscholar +2 more sources
Human papillomavirus infection
Journal of the American Academy of Dermatology, 1990The human papillomavirus, well known as the etiologic agent of warts, has recently received much attention in the medical literature for its association with various cancers. This article discusses the virology, epidemiology, pathogenesis, immunology, clinical manifestations, and therapy for human papillomavirus infection.
openaire +3 more sources
Immunology of papillomavirus infection
Current Opinion in Immunology, 1996Studies of the immunology of papillomavirus infection have come of age. Synthetic virus-like particles have been validated as vaccines for several animal papillomaviruses, and have been used to map the sero-epidemiology of human papillomavirus infection and to define papillomavirus neutralizing antibodies.
openaire +4 more sources
Vaccines for papillomavirus infection
Virus Research, 2002Vaccines to prevent PV infection, utilising PV L1 virus like particles (VLPs) to induce neutralising antibody, are in clinical trial and show all the characteristics likely to be associated with success. Results warrant global planning for the deployment of VLP vaccines within a decade, as part of a program to prevent cervical cancer. Vaccines designed
openaire +4 more sources